Article
Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
Cancer research - 1 Jul 2007
Wu Min, Min Chengyin, Wang Xiaobo, Yu Ziyang, Kirsch Kathrin H, Trackman Philip C, Sonenshein Gail E
Abstract excerpt
The gene encoding lysyl oxidase (LOX) was identified as the ras recision gene (rrg), with the ability to revert Ras-mediated transformation of NIH 3T3 fibroblasts. Mutations in RAS genes have been found in approximately 25% of lung cancers and in 85% of pancreatic cancers. In microarray analysis,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
